Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system

Acta Neuropathologica

Volumn 104, Issue 1, 2002, Pages 105-109

  Sasaki, Tsutomu ^a   Lopes, M Beatriz S ^a   Hankins, Gerald R ^a   Helm, Gregory A ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Apoptosis protein inhibitor; Brain tumor; Caspase inhibitor; Survivin; Tumor

Indexed keywords

CASPASE 3; CASPASE 7; FORMALDEHYDE; INHIBITOR OF APOPTOSIS PROTEIN; PARAFFIN; PROTEIN ANTIBODY; SURVIVIN;

ARTICLE; ASTROCYTOMA; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO CELL; ENZYME BINDING; EPENDYMOMA; GIANT CELL TUMOR; GLIOBLASTOMA; GLIOSARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MENINGIOMA; NERVOUS SYSTEM TUMOR; NEURILEMOMA; NEUROFIBROMA; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINOBLASTOMA; TUMOR CLASSIFICATION;

ASTROCYTOMA; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHROMOSOMAL PROTEINS, NON-HISTONE; EPENDYMOMA; HUMANS; MEDULLOBLASTOMA; MENINGEAL NEOPLASMS; MENINGIOMA; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OLIGODENDROGLIOMA; PROGNOSIS; RETINAL NEOPLASMS; RETINOBLASTOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0036943193     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-002-0532-x     Document Type: Article

References (30)

1. Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri D (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351:882-883
2. Adida C, Crotty P, McGrath J, Berrebi D, Diebold J, Altieri D (1998) Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152:43-49
3. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri D, Molina T (2000) Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96:1921-1925
4. Adida C, Recher C, Raffoux E, Daniel MT, Taksin AL, Rousselot P, Sigaux F, Degos L, Altieri DC, Dombret H (2000) Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol 111: 196-203
5. Ambrosini G, Adida C, Altieri D (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921
6. Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D, Watanabe N (2000) Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res 91:1204-1209
7. Banks DP, Plescia J, Altieri DC, Chen J, Rosenberg SH, Zhang H, Ng SC (2000) Survivin does not inhibit caspase-3 activity. Blood 96:4002-4003
8. Chiodino C, Cesinaro A, Ottani D, Fantini F, Giannetti A, Trentini G, Pincelli C (1999) Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 113:415-418
9. Grossman D, McNiff J, Li F, Altieri D (1999) Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 113:1076-1081
10. Grossman D, McNiff J, Li F, Altieri D (1999) Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79: 1121-1126
11. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580
12. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A (2000) High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19:617-623
13. Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, Nakano T, Suzuki A (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31:1080-1085
14. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, Fujii Y (2001) Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92-95
15. Kawasaki H, Altieri D, Lu C, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071-5074
16. Li F, Ambrosini G, Chu E, Plescia J, Tognin S, Marchisio P, Altieri D (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584
17. Lu C, Altieri D, Tanigawa N (1998) Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58: 1808-1812
18. Monzo M, Rosell R, Felip E, Astudillo J, Sanchez J, Maestre J, Martin C, Font A, Barnadas A, Abad A (1999) A novel antiapoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17:2100-2104
19. Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y (2001) Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163:109-116
20. Saitoh Y, Yaginuma Y, Ishikawa M (1999) Analysis of Bcl-2, Bax and survivin genes in uterine cancer. Int J Oncol 15:137-141
21. Sarela A, Macadam R, Farmery S, Makham A, Guillou P (2000) Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46:645-650
22. Sarela AI, Scott N, Ramsdale J, Markham AF, Guillou PJ (2001) Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 8:305-310
23. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117-1123
24. Skoufias DA, Mollinari C, Lacroix FB, Margolis RL (2000) Human survivin is a kinetochore-associated passenger protein. J Cell Biol 151:1575-1582
25. Suzuki A, Hayashida M, Ito T, Kawano H, Nakano T, Miura M, Akahane K, Shiraki K (2000) Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene 19:3225-3234
26. Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M, Shiraki K (2000) Survivin initiates procaspase3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19:1346-1353
27. Swana H, Grossman D, Anthony J, Weiss R, Altieri D (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452-453
28. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320
29. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127-134
30. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR (2000) The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 113: 4363-4371